Floatz logo

Therapeutic Asset Ratings

176 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Anamorelin
Non-Small Cell Lung Cancer
Helsinn Healthcare SAP3BB (68)
Atezolizumab
Non-Small Cell Lung Cancer
National Cancer Institute (NCI)P4BB (67)
Docetaxel
Non-Small Cell Lung Cancer
Genfleet Therapeutics (Shanghai) Inc.P4BB (67)
ETOPOSIDE
Non-Small Cell Lung Cancer
PfizerP3BB (67)
ALECTINIB
Non-Small Cell Lung Cancer
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairP4BB (66)
Panobinostat
Non-Small Cell Lung Cancer
PfizerP4BB (66)
Befotertinib
Non-Small Cell Lung Cancer
Hebei Medical University Fourth HospitalP3BB (66)
Irinotecan
Non-Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie ThoraciqueP3BB (66)
(+)-VINCRISTINE
Non-Small Cell Lung Cancer
PfizerP3BB (66)
Ensartinib
Non-Small Cell Lung Cancer
Qiming WangP4B (63)
Divarasib
Non-Small Cell Lung Cancer
Hoffmann-La RocheP3B (63)
Sunvozertinib
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd.P3B (63)
Eloxatin
Non-Small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.P3B (62)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Non-Small Cell Lung Cancer
University of ChicagoP3B (62)
Ivonescimab
Non-Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTCP3B (62)
PANITUMUMAB
Non-Small Cell Lung Cancer
Astellas Pharma IncP2B (62)
Sorafenib
Non-Small Cell Lung Cancer
Jian ChenP3B (61)
Trastuzumab Deruxtecan
Non-Small Cell Lung Cancer
National Cancer Institute (NCI)P3B (61)
Bms-907351
Non-Small Cell Lung Cancer
Jun Zhang, MD, PhDP3B (60)
Ceritinib
Non-Small Cell Lung Cancer
PfizerP3B (60)
Cyclophosphamide
Non-Small Cell Lung Cancer
University of PennsylvaniaP3B (60)
Npi-2358
Non-Small Cell Lung Cancer
BeyondSpring Pharmaceuticals Inc.P3B (60)
Palbociclib
Non-Small Cell Lung Cancer
PfizerP2B (60)
Cytosin-Arabinosid
Non-Small Cell Lung Cancer
PfizerP3B (58)
Datopotamab Deruxtecan
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer CenterP3B (58)
Showing 1 to 25 of 176 assets
PreviousPage 1 of 8Next